Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5387 ARTÍCULOS , VIENDO DEL 4711 AL 4725

Content of botulinum neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®

Frevert J.

Drugs R D. 2010;10(2):67-73. doi: 10.2165/11584780-000000000-00000.

Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications

Naumann M, Carruthers A, Carruthers J, Aurora SK, Zafonte R, Abu-Shakra S, Boodhoo T, Miller-Messana MA, Demos G, James L, Beddingfield F, VanDenburgh A, Chapman MA, Brin MF.

Mov Disord. 2010 Oct 15;25(13):2211-8. doi: 10.1002/mds.23254.

Assessment and treatment of movement disorders in children with cerebral palsy

Deon LL, Gaebler-Spira D.

Orthop Clin North Am. 2010 Oct;41(4):507-17. doi: 10.1016/j.ocl.2010.06.001.

How to clinically assess and treat muscle overactivity in spastic paresis

Yelnik AP, Simon O, Parratte B, Gracies JM.

J Rehabil Med. 2010 Oct;42(9):801-7. doi: 10.2340/16501977-0613.

Botulinum toxin type A: Exploring new indications

Brashear A.

Drugs Today (Barc). 2010 Sep;46(9):671-82. doi: 10.1358/dot.2010.46.9.1524356.

Use of botulinum toxin in the neurology clinic

Lim EC, Seet RC.

Nat Rev Neurol. 2010 Nov;6(11):624-36. doi: 10.1038/nrneurol.2010.149. Epub 2010 Oct 12.

Allan-Herndon-Dudley Syndrome

Sarret C, Oliver Petit I, Tonduti D.

2010 Mar 9 [updated 2020 Jan 16]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Semi-dominant X-chromosome linked learning disability with progressive ataxia, spasticity and dystonia associated with the novel MECP2 variant p.V122A: akin to the new MECP2 duplication syndrome?

McWilliam C, Cooke A, Lobo D, Warner J, Taylor M, Tolmie JL.

Eur J Paediatr Neurol. 2010 May;14(3):267-9. doi: 10.1016/j.ejpn.2009.06.007. Epub 2009 Jul 9.

Paraneoplastic ataxia and dystonia secondary to a malignant fibrous histiocytoma

Dolan R, Thomas R, O'Riordan JI.

BMJ Case Rep. 2010 Nov 12;2010:bcr0520102983. doi: 10.1136/bcr.05.2010.2983.

Copper deficiency associated with severe neurological disorder--a genetic work-up of possible mutations in copper transport proteins

Bach JP, Kumar N, Depboylu C, Noelker C, Klockgether T, Bacher M, Balzer-Geldsetzer M, Dodel R.

J Neurol Sci. 2010 Apr 15;291(1-2):95-7. doi: 10.1016/j.jns.2010.01.008. Epub 2010 Feb 11.

Uncovering microdeletions in patients with severe Glut-1 deficiency syndrome using SNP oligonucleotide microarray analysis

Levy B, Wang D, Ullner PM, Engelstad K, Yang H, Nahum O, Chung WK, De Vivo DC.

Mol Genet Metab. 2010 Jun;100(2):129-35. doi: 10.1016/j.ymgme.2010.03.007. Epub 2010 Mar 17.

Leukoencephalopathy with brainstem and spinal cord involvement and normal lactate: a new mutation in the DARS2 gene

Lin J, Chiconelli Faria E, Da Rocha AJ, Rodrigues Masruha M, Pereira Vilanova LC, Scheper GC, Van der Knaap MS.

J Child Neurol. 2010 Nov;25(11):1425-8. doi: 10.1177/0883073810370897. Epub 2010 May 25.

Torticollis as the only manifestation of acute disseminated encephalomyelitis

Har-Gil M, Evrani M, Watemberg N.

J Child Neurol. 2010 Nov;25(11):1415-8. doi: 10.1177/0883073810368995. Epub 2010 Jul 6.

Dentatorubropallidoluysian atrophy without involuntary movement or dementia--a case report

Kasahata N, Iwasaki Y.

Clin Neurol Neurosurg. 2010 Oct;112(8):722-5. doi: 10.1016/j.clineuro.2010.04.023. Epub 2010 Jun 2.

Tremor-ataxia with central hypomyelination (TACH) leukodystrophy maps to chromosome 10q22.3-10q23.31

Bernard G, Thiffault I, Tetreault M, Putorti ML, Bouchard I, Sylvain M, Melançon S, Laframboise R, Langevin P, Bouchard JP, Vanasse M, Vanderver A, Sébire G, Brais B.

Neurogenetics. 2010 Oct;11(4):457-64. doi: 10.1007/s10048-010-0251-8. Epub 2010 Jul 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias